Mindfulness-informed Intervention for Improving Diabetes Outcomes in Type 2 Diabetes

Brief summary (registry, in English)

The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT), a mindfulness-based psychological approach, can improve health and emotional well-being in adults with type 2 diabetes. The main questions it aims to answer are: Can ACT reduce diabetes-related distress? Can ACT improve self-care behaviors? Can ACT improve psychological flexibility? Researchers will compare people who receive ACT to those in a waitlist control group to see if ACT has better effects on diabetes-related outcomes. Participants will: Attend ACT sessions tailored for people with type 2 diabetes Complete questionnaires about their health, mood, and self-care.

What you commit to

• Study type: Interventional
• Participants enrolled: 50
• From 1 Apr 2025 to the primary completion date, 15 Jul 2025
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.